This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs. Eligibility requires evaluation by a licensed healthcare professional and is not guaranteed. Compounded medications are not FDA-approved finished products. Pricing information reflects published rates at the time of writing and is subject to change — confirm current terms directly with each platform before enrolling. This article contains affiliate links.
Why This Comparison Exists
After publishing my Wellorithm review, readers started asking whether Gala GLP-1 was worth looking at instead — or alongside. The two platforms come up in the same searches, both offer compounded GLP-1 medications at sub-$200 monthly price points, and both use the same three-entity structure (platform + independent licensed providers + partner pharmacies) that is standard for this category. But they're meaningfully different in ways most comparisons don't explain. This article covers those differences.
For the full Wellorithm program review: Wellorithm Review 2026: What I Found After Researching the GLP-1 Telehealth Program. For the full Gala program review: Gala GLP-1 Review 2026: What I Found After Researching It.
The 2026 Context Both Platforms Share
Both Gala and Wellorithm offer compounded GLP-1 medications in a regulatory environment that has changed significantly since the GLP-1 drug shortages ended. The FDA resolved the tirzepatide shortage in October 2024 and the semaglutide shortage in early 2025. Post-shortage, the FDA has drawn sharper lines around mass-produced compounded versions of these medications, and the legal standing of compounded programs in this category is more unsettled in 2026 than it was in 2023. Neither platform can guarantee its compounding operations will remain unchanged as that regulatory picture continues to evolve. Before enrolling in either program, confirming the specific pharmacy's current regulatory status with your prescribing clinician is worth doing. For a detailed breakdown of what compounded means in this context, see: What Compounded Semaglutide Actually Means: A Plain-Language Guide for 2026.
Gala GLP-1
Operator: AI Coaching, Inc., Wilmington, Delaware.
Medication focus: Compounded tirzepatide — GLP-1/GIP dual agonist. Two tracks: standard ($179/mo on 3-month plan; $199/mo per FAQ monthly rate) and microdosing ($149/mo on 3-month plan). Brand-name Ozempic also listed at $1,299/mo.
Geographic coverage: All 50 states.
Consultation: Synchronous (video) or asynchronous depending on state, patient profile, and medication type; video typically at initial session only.
Billing: Refunds issued only on medical disqualification; no standard cancellation refunds; 72-hour pre-billing cancellation notice required.
Insurance: Cash-pay only.
Independent reviews: 974 Trustpilot reviews, 4.4 rating. App: Gala GLP-1 Tracker (iOS ~4.5 stars, ~390 reviews per available data).
Contact: [email protected].
What stands out: The microdosing track at $149/mo is a genuine differentiator — Wellorithm has no equivalent. All-50-states coverage includes Louisiana, where Wellorithm is not available. The tirzepatide/GLP-1/GIP dual agonist mechanism is a different pharmacological approach than semaglutide's single-pathway mechanism, which may matter clinically depending on your provider's assessment. The Trustpilot record (974 reviews, 4.4 rating) provides more independent patient signal than Wellorithm's available record.
What to verify: The $179/$199 pricing discrepancy in Gala's own materials — confirm at checkout. Pharmacy partners are not publicly named — ask directly. No-refund billing policy on standard cancellations is the same risk exposure as Wellorithm, at a higher price point for the standard track.
Wellorithm
Operator: Wellorithm (platform structure; specific corporate entity details per Wellorithm's published documentation).
Medication focus: Compounded semaglutide (primary) and compounded tirzepatide. Both injectable and oral dissolving tablet formats available.
Starting price: Compounded semaglutide at $147/mo; compounded tirzepatide at $249/mo, per published pricing.
Geographic coverage: 49 states (Louisiana excluded).
Consultation: Two-minute online health quiz intake; virtual clinician consultation if candidate.
Billing: 28-day recurring cycle; payments non-refundable once processed; cancel anytime via email.
Insurance: Cash-pay only.
Independent reviews: No significant Trustpilot or BBB record found in available research.
Support: 24/7 phone and email.
What stands out: The $147/mo semaglutide entry price is the lower absolute starting point between the two platforms for the semaglutide track. Injectable and oral dissolving tablet formats give patients more flexibility in delivery method. 24/7 phone support is a real differentiator for a program dealing with medications that have a meaningful side effect profile.
What to verify: The absence of a significant independent review record makes real-world patient experience harder to assess. Pharmacy partners are not publicly listed. The no-refund billing policy is the same category of risk as Gala's.
Head-to-Head on the Six Variables That Matter
Medication focus: Gala leads with tirzepatide (GLP-1/GIP dual agonist). Wellorithm leads with semaglutide (GLP-1 single agonist). The clinical difference is mechanism and, in clinical trial data from the SURMOUNT program, tirzepatide showed pronounced average weight effects — though those trials were conducted at standard doses, not the sub-therapeutic doses in Gala's microdosing track, and involved FDA-approved brand-name drug conditions rather than compounded preparations. Your prescribing clinician is the right person to evaluate which mechanism is appropriate for you specifically.
Entry price: Wellorithm's semaglutide at $147/mo is the lower number — but only if semaglutide is appropriate for your situation. Gala's microdosing track at $149/mo is effectively comparable. Gala's standard tirzepatide track at $179-$199/mo is higher. Wellorithm's tirzepatide at $249/mo is the highest of the group.
Microdosing: Gala has a dedicated track. Wellorithm does not. If starting below standard doses is a priority for you — whether for side effect management or the lower monthly cost — this is a meaningful practical difference.
Geographic coverage: Gala serves all 50 states. Wellorithm serves 49, with Louisiana excluded. For Louisiana residents, this resolves the comparison immediately.
Refund policy: Both platforms have no-refund policies for standard cancellations. The mechanisms differ slightly: Gala requires 72-hour advance cancellation notice and refunds only on medical disqualification; Wellorithm's billing terms indicate payments are non-refundable once processed with cancel-anytime by email. The practical reality is the same — neither is a risk-free trial once a prescription is issued and medication ships.
Independent review footprint: Gala has 974 Trustpilot reviews at 4.4 stars. Wellorithm has a thinner publicly verifiable review record. This is a signal, not a verdict — a newer platform may simply have had less time to accumulate public reviews. But more independent signal is generally better when evaluating a platform handling prescription medication billing.
How to Choose
If semaglutide is the right medication for your situation and budget is the primary driver: Wellorithm's $147/mo entry price is the lower absolute number. Understand the no-refund policy and the thinner independent review record, and do your due diligence on the pharmacy before your first shipment.
If tirzepatide is appropriate for your situation or your provider recommends the GLP-1/GIP dual agonist mechanism: Gala is the more logical choice, with the standard track at $179-$199/mo and more independent review signal than Wellorithm.
If you're in Louisiana: Gala is the only option between the two.
If the microdosing approach appeals to you: Gala at $149/mo is the only platform between the two that offers a structured lower-dose entry. Go in with realistic expectations about the evidence base at sub-therapeutic doses — see the full breakdown in my explainer: What Is Gala GLP-1? A Plain-Language Guide for 2026.
If you want a larger established platform with more independent review data and format flexibility: Neither Gala nor Wellorithm is the comparison you're looking for. Hims, Ro, and WeightWatchers Clinic are more established platforms with years of independent review data in the public record. The broader landscape is covered in: Best GLP-1 Telehealth Programs 2026: What to Know Before You Choose.
Frequently Asked Questions
Is Gala GLP-1 cheaper than Wellorithm?
Wellorithm's compounded semaglutide starts at $147 per month, lower than Gala's $179 per month standard track. However, Gala's microdosing track is $149 per month — comparable to Wellorithm's entry price. The right comparison depends on which medication (semaglutide vs. tirzepatide) and which track is appropriate for your situation.
What is the difference between Gala and Wellorithm?
The primary differences are: medication focus (Gala leads with tirzepatide/GLP-1/GIP; Wellorithm leads with semaglutide), geographic coverage (Gala serves all 50 states; Wellorithm serves 49, excluding Louisiana), the availability of a dedicated microdosing track (Gala has one; Wellorithm does not), and independent review footprint (Gala has 974 Trustpilot reviews; Wellorithm has a thinner public record).
Which compounded GLP-1 program is better in 2026?
Neither is universally better. Wellorithm's semaglutide track is cheaper if semaglutide is appropriate for your situation. Gala's tirzepatide focus makes it a better fit for patients who want the GLP-1/GIP dual agonist mechanism or the microdosing option. For Louisiana residents, Gala is the only option between the two. The decision depends on your medication preference, clinical eligibility, and budget.
Leave a Reply
You must be logged in to post a comment.